Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19,203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma.
Chen Z, Huang H, Huang H, Yu L, Weng H, Xiao J, Zou L, Zhang H, Liang C, Zhou H, Guo H, Wang Z, Li Z, Wu T, Zhang H, Wu H, Peng Z, Zhai L, Chen X, Liang Y, Hong H, Lin T. Chen Z, et al. Among authors: wu h, wu t. Leukemia. 2024 Apr;38(4):829-839. doi: 10.1038/s41375-024-02171-4. Epub 2024 Feb 20. Leukemia. 2024. PMID: 38378844
Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG).
Qi SN, Xu LM, Yuan ZY, Wu T, Zhu SY, Shi M, Su H, Wang Y, He X, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Wu JX, Yang Y, Li YX. Qi SN, et al. Among authors: wu g, wu jx, wu t. Leuk Lymphoma. 2019 Nov;60(11):2669-2678. doi: 10.1080/10428194.2019.1602265. Epub 2019 May 7. Leuk Lymphoma. 2019. PMID: 31060406
A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group.
Hong H, Li Y, Lim ST, Liang C, Huang H, Yi P, Wu T, Du X, Zhang M, Wang J, Zhu J, Liu T, Meng F, Wu G, Guo Y, Zhu Y, Zhao W, Jin J, Li J, Deng Y, Gu K, Wu X, Ke X, Xie D, Lin D, Peng Z, Wu J, Liu Q, Kim WS, Lin T. Hong H, et al. Among authors: wu x, wu g, wu t, wu j. Leukemia. 2020 Aug;34(8):2243-2248. doi: 10.1038/s41375-020-0740-1. Epub 2020 Feb 17. Leukemia. 2020. PMID: 32066865 Free PMC article. No abstract available.
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.
Chen SY, Yang Y, Qi SN, Wang Y, Hu C, He X, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Qiao XY, Wang H, Li GF, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Wu JX, Wu T, Zhu SY, Shi M, Xu LM, Yuan ZY, Yahalom J, Tsang R, Song YQ, Zhu J, Su H, Li YX. Chen SY, et al. Among authors: wu g, wu jx, wu t. Leukemia. 2021 Jan;35(1):130-142. doi: 10.1038/s41375-020-0791-3. Epub 2020 Mar 9. Leukemia. 2021. PMID: 32152465 Free PMC article.
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study.
Yang Y, Wang Y, Liu X, He X, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Qiao XY, Wang H, Li GF, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Xu LM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Hu C, Qi SN, Li YX. Yang Y, et al. Among authors: wu g, wu jx, wu t. Leukemia. 2021 Jun;35(6):1671-1682. doi: 10.1038/s41375-020-01042-y. Epub 2020 Sep 17. Leukemia. 2021. PMID: 32943751 Free PMC article.
Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study.
Yang Y, Wang Y, Liu X, He X, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Qiao XY, Wang H, Li GF, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Xu LM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Hu C, Qi SN, Li YX. Yang Y, et al. Among authors: wu g, wu jx, wu t. Leukemia. 2021 Sep;35(9):2736-2737. doi: 10.1038/s41375-021-01371-6. Leukemia. 2021. PMID: 34341480 Free PMC article. No abstract available.
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database.
Zheng X, Qu BL, Liu X, Zhong QZ, Qian LT, Yang Y, Hou XR, Qiao XY, Wang H, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Zhang XM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Wang Y, Chen F, Yin L, He X, Zhang LL, Li YX, Qi SN. Zheng X, et al. Among authors: wu jx, wu t. EJHaem. 2022 Nov 25;4(1):78-89. doi: 10.1002/jha2.613. eCollection 2023 Feb. EJHaem. 2022. PMID: 36819187 Free PMC article.
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma.
Liu JX, Liu X, Yang Y, Liu WP, Wang Y, He X, Zhang LL, Qu BL, Qian LT, Hou XR, Qiao XY, Wang H, Li GF, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Su H, Zhang YJ, Zhu J, Qi SN, Li YX, Song YQ. Liu JX, et al. Among authors: wu jx, wu t. Cancer Rep (Hoboken). 2023 May;6(5):e1800. doi: 10.1002/cnr2.1800. Epub 2023 Mar 15. Cancer Rep (Hoboken). 2023. PMID: 36919649 Free PMC article.
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group.
Wu T, Yang Y, Zhu SY, Shi M, Su H, Wang Y, He X, Xu LM, Yuan ZY, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Wu JX, Hu C, Qi SN, Chen B, Li YX. Wu T, et al. Among authors: wu g, wu jx. Blood Adv. 2018 Sep 25;2(18):2369-2377. doi: 10.1182/bloodadvances.2018021311. Blood Adv. 2018. PMID: 30242098 Free PMC article.
19,203 results
You have reached the last available page of results. Please see the User Guide for more information.